Patents by Inventor Terry Lyle

Terry Lyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951650
    Abstract: A protectant and sealant solution and method of use thereof, configured to protect wood from premature decay when disposed in contact with the earth. The solution is composed of processed hemp oil which is mixed with bio-diesel and other oils to form the protectant solution. The wood is then impregnated with the solution via pressure treatment within a retort cylinder. The solution is configured to protect utility poles and other wooden construction members which are known for prolonged contact with soil. The solution is designed as a safe replacement for pentachlorophenol solutions which have been found to be harmful to the soil and water table.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: April 9, 2024
    Assignee: Smart Green Utility Pole, LLC.
    Inventors: Terry Lyles, Michael Baughman, Hollis Ervin
  • Publication number: 20230044862
    Abstract: A protectant and sealant solution and method of use thereof, configured to protect wood from premature decay when disposed in contact with the earth. The solution is composed of processed hemp oil which is mixed with bio-diesel and other oils to form the protectant solution. The wood is then impregnated with the solution via pressure treatment within a retort cylinder. The solution is configured to protect utility poles and other wooden construction members which are known for prolonged contact with soil. The solution is designed as a safe replacement for pentachlorophenol solutions which have been found to be harmful to the soil and water table.
    Type: Application
    Filed: July 27, 2022
    Publication date: February 9, 2023
    Inventors: Terry Lyles, Michael Baughman
  • Patent number: 8135795
    Abstract: Method, apparatus and article of manufacture for on-demand access to computerized resources. A resource-time value includes a resource-identifying component and a usage limit component. The resource-identifying component specifies a given type of a resource and the usage limit component defines a maximum allowable usage value of the resource on the basis of time and quantity. Upon verifying the resource-time value, a quantity of the resource is enabled. The enabled resources may then be placed into service for specified time periods, wherein the quantity of resources placed into service and the time periods are delimited by the usage limit component.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: March 13, 2012
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Patent number: 8074225
    Abstract: A capacity manager provides temporary resources on demand in a manner that assures the temporary resources may be recovered when the specified resource-time expires. Access to minimum resource specifications corresponding to the logical partitions is controlled to prevent the sum of all minimum resource specifications from exceeding the base resources on the system. By assuring the sum of minimum resource specifications for all logical partitions is satisfied by the base resources on the system, the temporary resources may always be recovered when required.
    Type: Grant
    Filed: June 6, 2008
    Date of Patent: December 6, 2011
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Terry Lyle Schardt
  • Patent number: 7958218
    Abstract: An apparatus, program product and method for determining unreturned standby resource usage. Unreturned standby resource data is monitored and stored separately from other standby resource data for billing and other accounting purposes.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: June 7, 2011
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Publication number: 20100056516
    Abstract: 1-Hydroxy naphthyridine compounds (e.g., 1-hydroxy naphthyridin-2(1H)-one compounds of Formula I are inhibitors of HIV integrase and/or HIV RNase H and inhibitors of HIV replication: (I) wherein X and R1-R6 are as defined herein. The compounds are useful in the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other anti-HIV agents such as HIV antivirals, immunomodulators, antibiotics and vaccines.
    Type: Application
    Filed: July 13, 2007
    Publication date: March 4, 2010
    Inventors: Peter D. Williams, Shankar Venkatraman, H. Marie Langford, Boyoung Kim, Theresa M. Booth, Jay A. Grobler, Donnette Staas, Rowena D. Ruzek, Mark W. Embrey, Catherine M. Wiscount, Terry A. Lyle
  • Publication number: 20100005665
    Abstract: A craft knife has an automatic light and is constructed of two electrically conductive cylindrical handle parts insulated from each other by a dielectric possessing on one end a clear blade/tool clamping collet with the capacity to transmit light from its base or threaded end, to its spherical end and thus illuminate the blade, blade tip and work area.
    Type: Application
    Filed: July 6, 2009
    Publication date: January 14, 2010
    Inventors: Victoria Jean Elliott, Terry Lyle Flynn
  • Publication number: 20090312335
    Abstract: Substituted hydroxytetrahydropyrrolopyrazinone and substituted hydroxytetrahydro-pyrazolopyrazinone compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein R1, R2, R3, R4; R5, X, ring A, and Q are as defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: October 23, 2006
    Publication date: December 17, 2009
    Inventors: John S Wai, Peter D. Williams, Terry A. Lyle
  • Patent number: 7627506
    Abstract: An apparatus and method provides the capability of metering temporary capacity on demand in a computer system. A resource-time is specified, such as processor-days. The actual usage of the resource is monitored, and the customer is charged for only the actual usage of the resource. In this manner a customer may purchase a specified resource-time, and is only charged for the time that the resource is actually used. The preferred embodiments extend to metering temporary capacity on demand in a logically partitioned computer system. If a resource is shared, the actual usage of the resource is monitored, and the customer is only billed for actual usage that exceeds a predetermined non-zero threshold.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: December 1, 2009
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Patent number: 7619086
    Abstract: Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein Z, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: November 17, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Matthew M. Morrissette, Peter D. Williams, John S. Wai, Thorsten E. Fisher, Terry A. Lyle
  • Patent number: 7594231
    Abstract: A capacity manager provides temporary resources on demand in a manner that assures the temporary resources may be recovered when the specified resource-time expires. Access to minimum resource specifications corresponding to the logical partitions is controlled to prevent the sum of all minimum resource specifications from exceeding the base resources on the system. By assuring the sum of minimum resource specifications for all logical partitions is satisfied by the base resources on the system, the temporary resources may always be recovered when required.
    Type: Grant
    Filed: July 10, 2003
    Date of Patent: September 22, 2009
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Terry Lyle Schardt
  • Patent number: 7574507
    Abstract: An apparatus, program product and method for determining unreturned standby resource usage. Unreturned standby resource data is monitored and stored separately from other standby resource data for billing and other accounting purposes.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: August 11, 2009
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Patent number: 7538112
    Abstract: Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: May 3, 2005
    Date of Patent: May 26, 2009
    Assignee: Merck & Co., Inc.
    Inventors: John S. Wai, Joseph P. Vacca, Linghang Zhuang, Boyoung Kim, Terry A. Lyle, Catherine M. Wiscount, Melissa S. Egbertson, Lou Anne Neilson, Mark Embrey, Thorsten E. Fisher, Donnette D. Staas
  • Publication number: 20080287394
    Abstract: Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: May 3, 2005
    Publication date: November 20, 2008
    Applicant: MERCK & CO., INC.
    Inventors: John S. Wai, Joseph P. Vacca, Linghang Zhuang, Boyoung Kim, Terry A. Lyle, Catherine M. Wiscount, Melissa S. Egbertson, Lou Anne Neilson, Mark Embrey, Thorsten E. Fisher, Donnette D. Staas
  • Patent number: 7435735
    Abstract: Hydroxy-substituted pyridopyrrolopyrazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I): (I) wherein a, b, A, B, R1, R2, R3, R4, R5, R6, R7 and R8 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: October 14, 2008
    Assignee: Merck & Co., Inc.
    Inventors: John S. Wai, Thorsten E. Fisher, Linghang Zhuang, Donnette D. Staas, Terry A. Lyle, Boyoung Kim, Mark W. Embrey, Catherine M. Wiscount, Lekhanh O. Tran, Melissa Egbertson, Kelly L. Savage
  • Publication number: 20080244609
    Abstract: A capacity manager provides temporary resources on demand in a manner that assures the temporary resources may be recovered when the specified resource-time expires. Access to minimum resource specifications corresponding to the logical partitions is controlled to prevent the sum of all minimum resource specifications from exceeding the base resources on the system. By assuring the sum of minimum resource specifications for all logical partitions is satisfied by the base resources on the system, the temporary resources may always be recovered when required.
    Type: Application
    Filed: June 6, 2008
    Publication date: October 2, 2008
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Daniel Charles Birkestrand, Terry Lyle Schardt
  • Publication number: 20080228644
    Abstract: An apparatus and method provides the capability of metering temporary capacity on demand in a computer system. A resource-time is specified, such as processor-days. The actual usage of the resource is monitored, and the customer is charged for only the actual usage of the resource. In this manner a customer may purchase a specified resource-time, and is only charged for the time that the resource is actually used. The preferred embodiments extend to metering temporary capacity on demand in a logically partitioned computer system. If a resource is shared, the actual usage of the resource is monitored, and the customer is only billed for actual usage that exceeds a predetermined non-zero threshold.
    Type: Application
    Filed: May 31, 2008
    Publication date: September 18, 2008
    Applicant: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Patent number: 7395334
    Abstract: An apparatus, program product and method for determining unreturned standby resource usage. Unreturned standby resource data is monitored and stored separately from other standby resource data for billing and other accounting purposes.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: July 1, 2008
    Assignee: International Business Machines Corporation
    Inventors: Daniel Charles Birkestrand, Randall Lane Grimm, David Otto Lewis, Terry Lyle Schardt
  • Publication number: 20080139579
    Abstract: Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein Z, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: March 4, 2005
    Publication date: June 12, 2008
    Applicant: MERCK & CO., INC.
    Inventors: Matthew M. Morrissette, Peter D. Williams, John S. Wai, Thorsten E. Fisher, Terry A. Lyle
  • Publication number: 20070093496
    Abstract: Hydroxy-substituted pyridopyrrolopyrazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I): (I) wherein a, b, A, B, R1, R2, R3, R4, R5, R6, R7 and R8 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: October 18, 2004
    Publication date: April 26, 2007
    Inventors: John Wai, Thorsten Fisher, Linghang Zhuang, Donnette Staas, Terry Lyle, Boyoung Kim, Mark Embrey, Catherine Wiscount, Lekhanh Tran, Melissa Egbertson, Kelly Savage